Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saurav Misra

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Journal of Basic and Clinical Physiology and Pharmacology|April 10, 2024
Pozelimab, a human monoclonal immunoglobulin for the treatment of CHAPLE diseaseManmeet Kaur, Saurav Misra
Journal of Basic and Clinical Physiology and Pharmacology|July 8, 2024
Deucravacitinib: moderate-to-severe plaque psoriasis preventable?Manmeet Kaur, Saurav Misra
European Journal of Clinical Pharmacology|February 17, 2024
A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesityManmeet Kaur, Saurav Misra
Journal of Basic and Clinical Physiology and Pharmacology|October 10, 2024
Bimagrumab: an investigational human monoclonal antibody against activin type II receptors for treating obesityManmeet Kaur, Saurav Misra
Journal of Pharmacy & Bioallied Sciences|July 11, 2025
A Comprehensive Overview of US-FDA-Approved Anticancer Drugs and Biologics in 2023: An Observational StudyAjay Kumar Shukla, Saurav Misra
Journal of General Internal Medicine|March 1, 2023
The Use of Ivermectin in the Treatment of COVID-19Ajay Kumar Shukla, Saurav Misra
Journal of Basic and Clinical Physiology and Pharmacology|December 6, 2023
Evidences and therapeutic advantages of donanemab in the treatment of early Alzheimer's diseaseAjay Kumar Shukla, Saurav Misra
The New England Journal of Medicine|December 14, 2022
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19Ajay K Shukla, Saurav Misra
Journal of Basic and Clinical Physiology and Pharmacology|April 15, 2022
An overview of post COVID sequelaeAjay Kumar Shukla, Saurav Misra
European Journal of Clinical Pharmacology|April 2, 2023
Teplizumab: type 1 diabetes mellitus preventable?Saurav Misra, Ajay Kumar Shukla
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Journal of Basic and Clinical Physiology and Pharmacology|April 10, 2024
Pozelimab, a human monoclonal immunoglobulin for the treatment of CHAPLE diseaseManmeet Kaur, Saurav Misra
Journal of Basic and Clinical Physiology and Pharmacology|July 8, 2024
Deucravacitinib: moderate-to-severe plaque psoriasis preventable?Manmeet Kaur, Saurav Misra
European Journal of Clinical Pharmacology|February 17, 2024
A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesityManmeet Kaur, Saurav Misra
Journal of Basic and Clinical Physiology and Pharmacology|October 10, 2024
Bimagrumab: an investigational human monoclonal antibody against activin type II receptors for treating obesityManmeet Kaur, Saurav Misra
Journal of Pharmacy & Bioallied Sciences|July 11, 2025
A Comprehensive Overview of US-FDA-Approved Anticancer Drugs and Biologics in 2023: An Observational StudyAjay Kumar Shukla, Saurav Misra
Journal of General Internal Medicine|March 1, 2023
The Use of Ivermectin in the Treatment of COVID-19Ajay Kumar Shukla, Saurav Misra
Journal of Basic and Clinical Physiology and Pharmacology|December 6, 2023
Evidences and therapeutic advantages of donanemab in the treatment of early Alzheimer's diseaseAjay Kumar Shukla, Saurav Misra
The New England Journal of Medicine|December 14, 2022
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19Ajay K Shukla, Saurav Misra
Journal of Basic and Clinical Physiology and Pharmacology|April 15, 2022
An overview of post COVID sequelaeAjay Kumar Shukla, Saurav Misra
European Journal of Clinical Pharmacology|April 2, 2023
Teplizumab: type 1 diabetes mellitus preventable?Saurav Misra, Ajay Kumar Shukla
Pageof 9